This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Porrata LF, Ristow K, Witzig TE, Tuinistra N, Habermann TM, Inwards DJ et al. Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas. Leukemia 2007; 21: 2554–2556.
Leahy MF, Seymour JF, Hicks RJ, Turner JH . Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma. J Clin Oncol 2006; 24: 4418–4425.
Maloney DG . Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets. Semin Oncol 2005; 32 (1 Suppl 1): S19–S26.
Turner JH, Martindale AA, Boucek J, Claringbold PG, Leahy MF . 131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital. Cancer Biother Radiopharm 2003; 18: 513–524.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bishton, M., Hicks, R., Prince, H. et al. Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set. Leukemia 22, 2259–2260 (2008). https://doi.org/10.1038/leu.2008.116
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.116
This article is cited by
-
Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma
Tumor Biology (2016)
-
Reply to ‘Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independence data set’ by Mark J Bishton et al
Leukemia (2008)